Total Payments
$243,434
2024 Payments
$36,742
Companies
31
Transactions
319
Medicare Patients
11,572
Medicare Billing
$6.2M
Payment Breakdown by Category
Other$185,586 (76.2%)
Consulting$35,799 (14.7%)
Travel$16,606 (6.8%)
Food & Beverage$5,428 (2.2%)
Education$14.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $156,609 | 64 | 64.3% |
| Consulting Fee | $35,799 | 29 | 14.7% |
| Honoraria | $28,975 | 17 | 11.9% |
| Travel and Lodging | $16,606 | 79 | 6.8% |
| Food and Beverage | $5,428 | 124 | 2.2% |
| Education | $14.96 | 1 | 0.0% |
| Current or prospective ownership or investment interest | $2.00 | 2 | 0.0% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
General
$243,434
316 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $101,199 | 109 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $63,046 | 68 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $53,222 | 73 | $0 (2022) |
| Merck Sharp & Dohme LLC | $12,503 | 14 | $0 (2024) |
| Lilly USA, LLC | $11,648 | 10 | $0 (2017) |
| Elekta, Inc. | $367.86 | 4 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $333.35 | 5 | $0 (2024) |
| Telix Pharmaceuticals | $166.86 | 3 | $0 (2024) |
| Galvanize Therapeutics, Inc | $145.00 | 1 | $0 (2023) |
| Medtronic USA, Inc. | $125.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,742 | 59 | Myriad Genetic Laboratories, Inc. ($27,980) |
| 2023 | $29,891 | 33 | Myriad Genetic Laboratories, Inc. ($19,301) |
| 2022 | $21,772 | 24 | Myriad Genetic Laboratories, Inc. ($15,765) |
| 2021 | $9,901 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($9,886) |
| 2020 | $17,491 | 17 | Bayer HealthCare Pharmaceuticals Inc. ($17,490) |
| 2019 | $6,168 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($5,779) |
| 2018 | $35,920 | 61 | Bayer HealthCare Pharmaceuticals Inc. ($26,757) |
| 2017 | $85,550 | 106 | E.R. Squibb & Sons, L.L.C. ($53,151) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $62.25 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/10/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/04/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.66 | General |
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $3,025.00 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $2,475.00 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,446.00 | General |
| Category: Oncology | ||||||
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $2,612.50 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $35.88 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $2,200.00 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,423.00 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Travel and Lodging | In-kind items and services | $1,184.62 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Honoraria | In-kind items and services | $4,400.00 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Honoraria | In-kind items and services | $1,650.00 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,754 | 21,214 | $6.5M | $1.7M |
| 2022 | 36 | 2,867 | 24,736 | $6.0M | $1.6M |
| 2021 | 37 | 3,034 | 24,681 | $5.9M | $1.5M |
| 2020 | 37 | 2,917 | 24,426 | $5.6M | $1.4M |
Total Patients
11,572
Total Services
95,057
Medicare Billing
$6.2M
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 283 | 322 | $1.3M | $378,913 | 30.2% |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | Office | 2023 | 71 | 430 | $1.2M | $355,311 | 29.3% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 116 | 868 | $1.1M | $253,520 | 24.0% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 74 | 83 | $510,284 | $122,991 | 24.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 132 | 990 | $445,100 | $96,502 | 21.7% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 266 | 315 | $200,970 | $87,001 | 43.3% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 59 | 70 | $273,000 | $81,207 | 29.7% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 25 | 51 | $243,270 | $41,764 | 17.2% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 81 | 264 | $138,336 | $39,651 | 28.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 75 | 99 | $158,400 | $36,886 | 23.3% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 100 | 360 | $99,000 | $25,146 | 25.4% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 23 | 131 | $90,914 | $24,933 | 27.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 79 | 99 | $89,100 | $18,473 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 251 | $44,427 | $15,692 | 35.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 94 | 94 | $48,222 | $15,511 | 32.2% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 97 | 163 | $76,250 | $15,298 | 20.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 86 | 267 | $59,433 | $14,061 | 23.7% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 22 | 68 | $53,176 | $13,071 | 24.6% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 88 | 91 | $40,950 | $12,120 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 122 | $32,452 | $11,625 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 64 | $22,976 | $8,320 | 36.2% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 23 | 130 | $30,686 | $7,818 | 25.5% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 18 | 18 | $29,340 | $6,621 | 22.6% |
| 71260 | Ct scan of chest w |